Related Experiment Video
Updated: Oct 29, 2025

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
MiR-17-5p and MKL-1 modulate stem cell characteristics of gastric cancer cells
Zhou-Tong Dai1, Yuan Xiang2, Yuan-Yuan Duan1
1Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, Hubei, 430081, P.R. China.
Abstract:
Effectively targeting cancer stem cells to treat cancer has great therapeutic prospects. However, the effect of microRNA miR-17/MKL-1 on gastric cancer stem cells has not been studied yet. This study preliminarily explored the mechanism of miR-17/MKL-1 in gastric cancer stem cells. Many previous reports have indicated that microRNA and EMT regulated cancer stem cell characteristics, and miR-17 and MKL-1 were involved as a critical gene in migration and invasion in the EMT pathway. Through RT-PCR, Western Blot, flow cytometry, immunofluorescence, sphere formation xenograft tumor assays and drug resistance, the role of miR-17-5p and MKL-1 on promoting stem cell-like properties of gastric cancer were verified in vivo and vitro. Next, MKL-1 targets CD44, EpCAM, and miR -17-5p promoter verified by luciferase assay and ChIP. Besides, the TCGA database analysis found that both miR-17-5p and MKL-1 increased in gastric cancer, and the prognostic survival of the MKL-1 high expression group was reduced. It is found that MKL-1 promotes expression by targeting miR-17, CD44 and EpCAM promoters. Besides, the TCGA database analysis found that both miR-17-5p and MKL-1 increased in gastric cancer, and the prognostic survival of the MKL-1 high expression group was reduced. These findings reveal new regulatory signaling pathways for gastric cancer stem cells, thus it give new insights on potential early diagnosis and/or molecular therapy for gastric cancer.
Insights
This study reveals microRNA miR-17 and MKL-1 promote gastric cancer stem cell properties. Targeting these may offer new therapeutic strategies for gastric cancer.
Area of Science:
- Molecular Oncology
- Cancer Stem Cell Biology
- Gastric Cancer Research
Background:
- Targeting cancer stem cells (CSCs) holds significant therapeutic promise for cancer treatment.
- The roles of microRNA (miRNA) and epithelial-mesenchymal transition (EMT) in regulating CSC characteristics are well-established.
- The specific involvement of miR-17 and MKL-1 in gastric CSCs remained unexplored.
Purpose of the Study:
- To investigate the mechanism of miR-17 and MKL-1 in gastric cancer stem cells.
- To explore the potential of miR-17 and MKL-1 as therapeutic targets in gastric cancer.
Main Methods:
- Utilized RT-PCR, Western Blot, flow cytometry, and immunofluorescence for cellular analysis.
- Employed sphere formation assays, xenograft tumor models, and drug resistance tests in vitro and vivo.
- Verified MKL-1 targets (CD44, EpCAM, miR-17-5p promoter) using luciferase assays and ChIP.
Main Results:
- miR-17-5p and MKL-1 were confirmed to promote stem cell-like properties in gastric cancer.
- MKL-1 was found to target the promoters of CD44, EpCAM, and miR-17-5p.
- TCGA database analysis showed increased miR-17-5p and MKL-1 in gastric cancer, with higher MKL-1 correlating with reduced survival.
Conclusions:
- Identified a novel regulatory pathway involving miR-17 and MKL-1 in gastric CSCs.
- These findings provide new insights into potential early diagnosis and molecular therapies for gastric cancer.
- MKL-1 promotes gastric cancer progression by targeting miR-17, CD44, and EpCAM.
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Mesenchymal Stem Cells

